ITeos Therapeutics Options Spot-On: On December 30th, 150.59K Contracts Were Traded, With 35,558 Open Interest
Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $19
ITeos Therapeutics Price Target Lowered to $19 From $31 at Wells Fargo
Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $19
ITeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21
